Earnings Alerts

Fisher & Paykel Healthcare Corp (FPH) Earnings Forecast Boost: A Deep Dive into FY Operating Revenue Predictions

  • F&P Healthcare has increased its FY operating revenue forecast to approximately NZ$1.73 billion, up from an estimate of NZ$1.72 billion.
  • The company’s updated guidance comes as the $NZ exchange rate is revised to about $0.61 for the rest of the fiscal year, compared to the previous forecast of $0.58.
  • The hospital group has seen a sustained demand for consumables across its product portfolio throughout the second half of the year, which is at the higher end of expectations set in November.
  • The Evora Full mask continues to perform well in the market, and the company has received positive feedback on the F&P Solo mask.
  • A revaluation of company-owned land is expected to impact net profit for FY24.
  • Due to the higher interest rate environment and the current zoning status, the Karaka property valuation is likely to decrease, although the exact amount of the potential reduction is currently unknown.
  • The FY24 earnings guidance excludes any potential non-cash effects resulting from a decrease in property value.
  • Current recommendations for the company’s stock include 2 buys, 6 holds, and 8 sells.
  • The comparisons made with past results are based on values reported by the company in its original disclosures.

A look at Fisher & Paykel Healthcare Corp Smart Scores

FactorScoreMagnitude
Value2
Dividend2
Growth3
Resilience4
Momentum5
OVERALL SMART SCORE3.2

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Fisher & Paykel Healthcare Corp, a company that specializes in heated humidification products for respiratory care and sleep apnea treatment, has been given an overall Smart Score of 3 out of 5. This score is based on a number of factors, including value, dividend, growth, resilience, and momentum. While the company scores a 2 in both value and dividend, its growth score is a 3, indicating a positive outlook for future growth. Additionally, the company scores a 4 in resilience, suggesting that it is well-equipped to handle potential challenges in the market. Most notably, Fisher & Paykel Healthcare Corp scores a 5 in momentum, indicating strong momentum and potential for future success.

Despite some lower scores in value and dividend, Fisher & Paykel Healthcare Corp appears to have a positive long-term outlook based on its Smart Scores. As a company that designs, manufactures, and markets products for respiratory and neonatal care, Fisher & Paykel Healthcare Corp is well-positioned for growth and resilience in the market. With a strong score of 5 in momentum, the company has a promising future ahead. Overall, Fisher & Paykel Healthcare Corp is a company with a solid foundation and potential for continued success in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars